The secreted glycoprotein CREG inhibits cell growth dependent on the mannose-6-phosphate/insulin-like growth factor II receptor

被引:82
|
作者
Di Bacco, A [1 ]
Gill, G [1 ]
机构
[1] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA
基金
美国国家卫生研究院;
关键词
cell proliferation; mannose-6-phosphate receptor; NTERA-2; tumor suppressor;
D O I
10.1038/sj.onc.1206670
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Secreted proteins and their cognate receptors are implicated in a myriad of activities that regulate cell proliferation, differentiation, and development. CREG, a cellular repressor of E1A-stimulated genes, is a secreted glycoprotein that antagonizes cellular transformation by E1A and ras. We have previously shown that CREG expression is induced very early during differentiation of pluripotent cells and, even in the absence of other inducers, CREG promotes neuronal differentiation of human teratocarcinoma NTERA-2 cells. Here we show that ectopic expression of CREG in NTERA-2 cells results in a delay of the G1/S phase transition of the cell cycle and growth inhibition. We show that CREG binds directly to the mannose-6-phosphate/insulin-like growth factor II receptor (M6P/IGF2R) dependent on CREG glycosylation. The M6P/IGF2R is a tumor suppressor that functions to control cell growth through interactions with multiple ligands. By analysing CREG activity in cells lacking M6P/IGF2R expression, we show that this receptor is required for CREG-induced growth inhibition. These studies reveal that CREG inhibits cell growth dependent on the M6P/IGF2R and suggest that interactions between CREG and a well-characterized tumor suppressor may contribute to regulation of proliferation and differentiation in multiple lineages.
引用
收藏
页码:5436 / 5445
页数:10
相关论文
共 50 条
  • [21] ETHANOL INHIBITS INSULIN-LIKE GROWTH FACTOR-1-MEDIATED SIGNALING AND PROLIFERATION OF C6 RAT GLIOBLASTOMA CELLS
    RESNICOFF, M
    RUBINI, M
    BASERGA, R
    RUBIN, R
    LABORATORY INVESTIGATION, 1994, 71 (05) : 657 - 662
  • [22] Amelioration of Diabetic Mouse Nephropathy by Catalpol Correlates with Down-Regulation of Grb10 Expression and Activation of Insulin-Like Growth Factor 1 / Insulin-Like Growth Factor 1 Receptor Signaling
    Yang, Shasha
    Deng, Huacong
    Zhang, Qunzhou
    Xie, Jing
    Zeng, Hui
    Jin, Xiaolong
    Ling, Zixi
    Shan, Qiaoyun
    Liu, Momo
    Ma, Yuefei
    Tang, Juan
    Wei, Qianping
    PLOS ONE, 2016, 11 (03):
  • [23] miR-133a suppresses ovarian cancer cell proliferation by directly targeting insulin-like growth factor 1 receptor
    Guo, Jinling
    Xia, Bairong
    Meng, Fanling
    Lou, Ge
    TUMOR BIOLOGY, 2014, 35 (02) : 1557 - 1564
  • [24] INSULIN-LIKE GROWTH-FACTOR REGULATION OF HUMAN ENDOMETRIAL STROMAL CELL-FUNCTION - COORDINATE EFFECTS ON INSULIN-LIKE GROWTH-FACTOR BINDING PROTEIN-1, CELL-PROLIFERATION AND PROLACTIN SECRETION
    IRWIN, JC
    FUENTES, LD
    DSUPIN, BA
    GIUDICE, LC
    REGULATORY PEPTIDES, 1993, 48 (1-2) : 165 - 177
  • [25] MicroRNA-30a Inhibits Colorectal Cancer Metastasis Through Down-Regulation of Type I Insulin-Like Growth Factor Receptor
    Liu, Y. C.
    Park, Y. R.
    Kim, S. L.
    Lee, S. T.
    Kim, S. W.
    DIGESTIVE DISEASES AND SCIENCES, 2017, 62 (11) : 3040 - 3049
  • [26] c-Met, epidermal growth factor receptor, and insulin-like growth factor-1 receptor are important for growth in uveal melanoma and independently contribute to migration and metastatic potential
    Wu, Xinqi
    Zhou, Jun
    Rogers, Andrew M.
    Jaenne, Pasi A.
    Benedettini, Elisa
    Loda, Massimo
    Hodi, F. Stephen
    MELANOMA RESEARCH, 2012, 22 (02) : 123 - 132
  • [27] Relaxin causes proliferation of human amniotic epithelium by stimulation of insulin-like growth factor-II
    Millar, LK
    Reiny, R
    Yamamoto, SY
    Okazaki, K
    Webster, L
    Bryant-Greenwood, GD
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2003, 188 (01) : 234 - 241
  • [28] miRNA-30a-3p inhibits metastasis and enhances radiosensitivity in esophageal carcinoma by targeting insulin-like growth factor 1 receptor
    Fan, Yanxin
    Bian, Xiuhua
    Qian, Pudong
    Wen, Jing
    Yan, Pengwei
    Luo, Yanhong
    Wu, Jing
    Zhang, Qian
    MOLECULAR MEDICINE REPORTS, 2019, 20 (01) : 81 - 94
  • [29] Autocrine secreted insulin-like growth factor-I stimulates MAP kinase-dependent mitogenic effects in human primitive neuroectodermal tumor/medulloblastoma
    Patti, R
    Reddy, CD
    Geoerger, B
    Grotzer, MA
    Raghunath, M
    Sutton, LN
    Phillips, PC
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2000, 16 (03) : 577 - 584
  • [30] The role of insulin-like growth factor-II in cancer growth and progression evidenced by the use of ribozymes and prostate cancer progression models
    Guo, N
    Ye, JJ
    Liang, SJ
    Mineo, R
    Li, SL
    Giannini, S
    Plymate, SR
    Sikes, RA
    Fujita-Yamaguchi, Y
    GROWTH HORMONE & IGF RESEARCH, 2003, 13 (01) : 44 - 53